IRIS
GIACOPPO, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.810
AS - Asia 1.791
EU - Europa 1.055
SA - Sud America 328
AF - Africa 75
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.063
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.764
SG - Singapore 783
CN - Cina 604
RU - Federazione Russa 548
IT - Italia 294
BR - Brasile 276
KR - Corea 177
VN - Vietnam 95
UA - Ucraina 58
IE - Irlanda 45
HK - Hong Kong 32
CA - Canada 30
BJ - Benin 29
CI - Costa d'Avorio 26
IN - India 23
AR - Argentina 21
NL - Olanda 20
BD - Bangladesh 17
GB - Regno Unito 15
FI - Finlandia 12
MX - Messico 12
ZA - Sudafrica 11
AT - Austria 10
ID - Indonesia 10
ES - Italia 9
TR - Turchia 9
EC - Ecuador 8
PL - Polonia 8
SE - Svezia 8
CO - Colombia 7
IR - Iran 6
JP - Giappone 6
DE - Germania 5
IQ - Iraq 5
PY - Paraguay 5
VE - Venezuela 4
AZ - Azerbaigian 3
BE - Belgio 3
BY - Bielorussia 3
CH - Svizzera 3
MA - Marocco 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
CL - Cile 2
EG - Egitto 2
FR - Francia 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
PE - Perù 2
PH - Filippine 2
UY - Uruguay 2
UZ - Uzbekistan 2
AU - Australia 1
BO - Bolivia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GR - Grecia 1
HN - Honduras 1
JO - Giordania 1
KH - Cambogia 1
KI - Kiribati 1
KZ - Kazakistan 1
LB - Libano 1
MG - Madagascar 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.063
Salva come PNG Salva come JPEG
Città #
Dallas 447
Santa Clara 433
Singapore 416
Hefei 351
Moscow 219
Seoul 177
Civitanova Marche 120
Chicago 103
Ashburn 100
Boardman 76
Jacksonville 64
Los Angeles 63
Dublin 45
Catania 38
Beijing 34
São Paulo 33
Chandler 32
Hong Kong 32
Cotonou 29
Abidjan 26
Buffalo 26
Ho Chi Minh City 26
Milan 25
New York 22
Nanjing 21
Hanoi 18
Orem 14
Toronto 14
Andover 13
Rome 13
Cambridge 12
Houston 12
Lawrence 12
Amsterdam 11
Palermo 11
Brooklyn 9
Chennai 9
Phoenix 9
Boston 8
Lappeenranta 8
Redondo Beach 8
San Mateo 8
Warsaw 8
San Francisco 7
Wilmington 7
Biên Hòa 6
London 6
Mascalucia 6
Montreal 6
Naples 6
Ottawa 6
Porto Alegre 6
Rio de Janeiro 6
Tehran 6
Tokyo 6
Ankara 5
Bari 5
Brasília 5
Curitiba 5
Denver 5
Des Moines 5
Hebei 5
Jiaxing 5
Johannesburg 5
Mexico City 5
Salvador 5
Shenyang 5
Stockholm 5
Turin 5
Atlanta 4
Bernareggio 4
Campinas 4
Can Tho 4
Dong Ket 4
Haiphong 4
Helsinki 4
Messina 4
Nanchang 4
Poplar 4
Querétaro 4
Sorocaba 4
Washington 4
Agerola 3
Baku 3
Barcelona 3
Bắc Giang 3
Bắc Ninh 3
Contagem 3
Council Bluffs 3
Dhaka 3
Elk Grove Village 3
Guarulhos 3
Guayaquil 3
Honolulu 3
Itaquaquecetuba 3
Mauá 3
Miami 3
Minsk 3
New Delhi 3
Norwalk 3
Totale 3.405
Salva come PNG Salva come JPEG
Nome #
Pharmacological and Clinical Appraisal of Factor XI Inhibitor Drugs. 123
Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. 123
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke : JACC State-of-the-Art Review 120
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 101
PCSK9 inhibitors: current status and emerging frontiers in lipid control 93
Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry) 93
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine 92
Spontaneous coronary artery dissection 89
Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence from a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients 85
Short and mid-term benefits of coronary stent system with nanothin Polyzene-F in acute coronary syndromes: preliminary result 82
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. 80
Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects 79
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? 79
Response by Giacoppo et al to Letter Regarding Article “Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis” 78
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology. 78
Mid-term clinical outcome of Catania coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 76
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry 76
Coronary Drug-Coated Balloons for De Novo and In-Stent Restenosis Indications. 75
Current developments in dual antiplatelet therapy after stenting 75
Association between surgical risk and 30‐day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta‐analysis. 75
Anticoagulation After Transcatheter Aortic Valve Replacement 74
A pairwise and network meta-analysis of anti-inflammatory strategies after myocardial infarction: the TITIAN study 73
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial 72
Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosis. 72
Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention. 70
Acute kidney injury after endovascular interventions for critical limb ischemia: Is that a whole different animal? 69
Usefulness of the logistic clinical SYNTAX score for predicting 1-year mortality in patients undergoing percutaneous coronary intervention of the left main coronary artery 68
Meta-analysis of Randomized Controlled Trials of Preprocedural Statin Administration for Reducing Contrast Induced Acute Kidney In Patients Undergoing Coronary Catheterization 68
Current Management of In-Stent Restenosis 67
Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis 66
Safety and efficacy of minimalist transcatheter aortic valve implantation using a new-generation balloon-expandable transcatheter heart valve in bicuspid and tricuspid aortic valves. 66
Changes in Coagulation Factor XI Activity Levels in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI 66
Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention 65
Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial. 64
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis. 64
Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated? 63
Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y12 Inhibitor Thereafter 62
Management of in-stent restenosis 62
Five‐year follow‐up of polymer‐free sirolimus‐ and probucol‐eluting stents versus new generation zotarolimus‐eluting stents in patients presenting with st‐elevation myocardial infarction 61
Mid-term clinical outcome of CATANIA Coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 61
Completeness, timing, and guidance of percutaneous coronary intervention for myocardial infarction and multivessel disease: a systematic review and network meta-analysis 61
Evaluation of a Low-Dose Radiation Protocol During Transcatheter Aortic Valve Implantation 59
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials 59
Dual antiplatelet therapy de-escalation by discontinuation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis 58
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis. 58
Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study). 58
Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials 57
Intraindividual Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Drug-Eluting Metallic Stents 55
Expanding indications for drug-coated balloons in coronary artery disease 55
Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials. 54
The Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 53
Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials. 53
Management of myocardial revascularisation failure: an expert consensus document of the EAPCI 52
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis. 52
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis. 52
Transcatheter versus surgical aortic valve replacement in the digital era: Meta‐analysis based on the reconstruction of time‐to‐event individual patient data. 51
Risk of stroke, atrial fibrillation, and major bleeding after mitral valve repair: the jury is still out. 51
Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents. 50
Optimal periprocedural antithrombotic therapy in percutaneous coronary intervention: Between a rock and a hard place? 49
Management of Patients Treated With Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention With Stent Implantation: The PERSEO Registry 49
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents. 47
P2Y 12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials 45
Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials 45
Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique. 45
Untangling the knot of the best endovascular treatment for femoropopliteal artery disease 44
Anti-inflammatory pharmacotherapy in patients with cardiovascular disease 43
Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention 43
Koronare Herzerkrankung mit Hauptstammbeteiliung 42
One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in patients at high-bleeding risk: an individual patient data pooled analysis of the SENIOR and POEM trials 41
Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry 40
Long-term effectiveness and safety of transcatheter closure of patent foramen ovale compared with antithrombotic therapy alone: a meta-analysis of six randomised clinical trials and 3,560 patients with reconstructed time-to-event data 39
Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease. 38
Reply: Completeness or complexity? A nuanced reflection on multivessel revascularisation 38
Targeting Inflammation After Acute Myocardial Infarction 37
Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention 36
Advances in the Detection and Management of Vulnerable Coronary Plaques 35
Trends in transcatheter aortic valve implantation practice and clinical outcomes at an Irish tertiary referral centre 35
Paclitaxel- or sirolimus-coated balloons for coronary bifurcations: is the side branch SPACIOUS enough for both? 35
Gli stent coronarici a rilascio di farmaco nella pratica interventistica contemporanea: progetto STENT PANORAMA (Parte I) 33
Predicting the risk of in-stent restenosis after drug-eluting stent implantation: Pipe dream or machine learning-enabled opportunity? 32
Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study 30
Off TARGET Effects in Stent Comparison Trials 28
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial 28
Molecular multimodality imaging: has a long-standing dream come true? 26
Radial artery access among mainstays of contemporary percutaneous coronary intervention: Is it time to forget how to puncture a femoral artery? 25
Impact of bystander-initiated cardiopulmonary resuscitation for out-of-hospital cardiac arrest: where would you be happy to have a cardiac arrest? 24
High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular Surgery 20
Totale 5.165
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.314
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 12 0 8 0 12 4
2021/202290 12 13 1 0 16 0 13 6 10 0 2 17
2022/2023127 12 1 1 9 20 21 0 18 40 1 0 4
2023/2024246 1 14 4 14 1 10 0 70 12 14 63 43
2024/20251.483 16 174 53 137 328 200 72 30 99 105 92 177
2025/20263.026 350 595 542 265 598 676 0 0 0 0 0 0
Totale 5.165